Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Valeritas

5 Disclosed Funding Rounds $355,000,000

0 Participating Investments


Medical Device, Health Care, Biotechnology, Diabetes

Valeritas is the developer of V-GO, a disposable insulin pump, and a micro needle patch for the treatment of Type 2 diabetes.

Bridgewater, New Jersey, United States, North America (US)

Organizations in Bridgewater in Medical Device,
Organizations in Bridgewater in Health Care,
Organizations in Bridgewater in Biotechnology,
Organizations in Bridgewater in Diabetes,
Organizations in New Jersey in Medical Device,
Organizations in New Jersey in Health Care,
Organizations in New Jersey in Biotechnology,
Organizations in New Jersey in Diabetes,
Organizations in United States in Medical Device,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in United States in Diabetes,
Organizations in North America in Medical Device,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology,
Organizations in North America in Diabetes

Investors in Bridgewater in Medical Device,
Investors in Bridgewater in Health Care,
Investors in Bridgewater in Biotechnology,
Investors in Bridgewater in Diabetes,
Investors in New Jersey in Medical Device,
Investors in New Jersey in Health Care,
Investors in New Jersey in Biotechnology,
Investors in New Jersey in Diabetes,
Investors in United States in Medical Device,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in United States in Diabetes,
Investors in North America in Medical Device,
Investors in North America in Health Care,
Investors in North America in Biotechnology,
Investors in North America in Diabetes

East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups)

Founded date 01, 2006

Founders Robert R. Gonnelli

Operating Status Active

Funding Stage M&A

Last Funding Type Series D

Company Type For Profit


Twitter Link

LinkedIN Link

Wikipedia Link

Valeritas is a medical technology company committed to developing and commercializing innovative drug delivery solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of diabetes. Valeritas' medical technologies portfolio is headlined by the h-Patch technology. The first use of the h-Patch technology will be the V-Go disposable insulin delivery device for continuous delivery both at a preset basal rate and for on-demand bolus dosing at mealtimes. The V-Go is a simple-to-use, once-daily, disposable insulin delivery device that provides a preset basal rate and on-demand bolus dosing for mealtime coverage via a mealtime insulin. The V-Go will enable the millions suffering from Type 2 diabetes to conveniently and discreetly deliver insulin throughout the day bolus dose on-demand around mealtimes. The h-Patch technology is also being developed to serve as a launching platform for applications across a wide spectrum of medical needs.

Date Round Raised Lead
July, 11, 2014 Series D $45,000,000 -------
June, 04, 2013 Debt Financing $100,000,000 -------
September, 12, 2011 Series C $150,000,000 Welsh, Carson, Anderson & Stowe
April, 01, 2011 Series B $10,000,000 -------
September, 10, 2008 Series A $50,000,000 -------

Valeritas Investors (25)

Investor Lead? Round Participating Raise Date Partners
Welsh, Carson, Anderson & Stowe No Series D $45,000,000 July, 11, 2014 -------
Advanced Technology Ventures No Series D $45,000,000 July, 11, 2014 -------
Kaiser Permanente Ventures No Series D $45,000,000 July, 11, 2014 -------
Abingworth No Series D $45,000,000 July, 11, 2014 -------
Pitango Venture Capital No Series D $45,000,000 July, 11, 2014 -------
MPM Capital No Series D $45,000,000 July, 11, 2014 -------
ONSET Ventures No Series D $45,000,000 July, 11, 2014 -------
CRG No Debt Financing $100,000,000 June, 04, 2013 -------
Welsh, Carson, Anderson & Stowe Yes Series C $150,000,000 September, 12, 2011 -------
CHL Medical Partners No Series C $150,000,000 September, 12, 2011 -------
ONSET Ventures No Series C $150,000,000 September, 12, 2011 -------
Pitango Venture Capital No Series C $150,000,000 September, 12, 2011 -------
Agate Medical Investments No Series C $150,000,000 September, 12, 2011 -------
MPM Capital No Series C $150,000,000 September, 12, 2011 -------
Kaiser Permanente Ventures No Series C $150,000,000 September, 12, 2011 -------
HLM Venture Partners No Series C $150,000,000 September, 12, 2011 -------
Advanced Technology Ventures No Series C $150,000,000 September, 12, 2011 -------
Abingworth No Series C $150,000,000 September, 12, 2011 -------
U.S. Venture Partners (USVP) No Series A $50,000,000 September, 10, 2008 -------
Pitango Venture Capital No Series A $50,000,000 September, 10, 2008 -------
ONSET Ventures No Series A $50,000,000 September, 10, 2008 -------
MPM Capital No Series A $50,000,000 September, 10, 2008 -------
HLM Venture Partners No Series A $50,000,000 September, 10, 2008 -------
Advanced Technology Ventures No Series A $50,000,000 September, 10, 2008 -------
Abingworth No Series A $50,000,000 September, 10, 2008 -------